Despite the fact that an integrative analysis based on independent datasets was undertaken and certain findings with potential values for therapeutic application were achieved, the role of COMP in the prognosis and immunotherapy for colon cancer should be prospectively validated. The gene discussed is COMP; the disease is malignant colon neoplasm.